ProfileGDS4718 / 210808_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 77% 72% 62% 78% 76% 88% 91% 81% 84% 84% 84% 75% 78% 88% 84% 86% 84% 76% 85% 67% 83% 81% 88% 81% 76% 80% 83% 70% 77% 72% 84% 94% 67% 83% 85% 85% 79% 79% 74% 60% 75% 72% 75% 85% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.49177
GSM549102patient 115, normal, homogenized [OPG study]7.0315672
GSM549104patient 119, normal, homogenized [OPG study]6.2830362
GSM549108patient 138, normal, homogenized [OPG study]7.5269978
GSM549119patient 077, normal, homogenized [OPG study]7.3411376
GSM549133patient 032, cancer, homogenized [OPG study]9.0053588
GSM549139patient 042, cancer, homogenized [OPG study]9.352991
GSM549099patient 107, normal, homogenized [OPG study]7.8879681
GSM549109patient 139, normal, homogenized [OPG study]8.273384
GSM549110patient 046, normal, homogenized [OPG study]8.3877184
GSM549114patient 063, normal, homogenized [OPG study]8.3923184
GSM549122patient 082, normal, homogenized [OPG study]7.3062275
GSM549134patient 033, cancer, homogenized [OPG study]7.6589178
GSM549136patient 036, cancer, homogenized [OPG study]8.896788
GSM549140patient 044, cancer, homogenized [OPG study]8.4757884
GSM549111patient 047, normal, homogenized [OPG study]8.6868586
GSM549113patient 057, normal, homogenized [OPG study]8.5411384
GSM549132patient 031, cancer, homogenized [OPG study]7.4807276
GSM549137patient 038, cancer, homogenized [OPG study]8.4970885
GSM549142patient 047, cancer, homogenized [OPG study]6.6788367
GSM549100patient 110, normal, homogenized [OPG study]8.1558283
GSM549107patient 135, normal, homogenized [OPG study]8.0068481
GSM549115patient 068, normal, homogenized [OPG study]9.0191488
GSM549116patient 072, normal, homogenized [OPG study]8.0511181
GSM549120patient 078, normal, homogenized [OPG study]7.4614576
GSM549131patient 030, cancer, homogenized [OPG study]7.9610580
GSM549118patient 074, normal, homogenized [OPG study]8.2198683
GSM549129patient 027, cancer, homogenized [OPG study]6.9154170
GSM549123patient 088, normal, homogenized [OPG study]7.5649677
GSM549124patient 006, cancer, homogenized [OPG study]6.9949872
GSM549126patient 015, cancer, homogenized [OPG study]8.2762484
GSM549128patient 025, cancer, homogenized [OPG study]9.9514194
GSM549103patient 117, normal, homogenized [OPG study]6.5863367
GSM549117patient 073, normal, homogenized [OPG study]8.2873383
GSM549138patient 041, cancer, homogenized [OPG study]8.4384585
GSM549141patient 045, cancer, homogenized [OPG study]8.6154585
GSM549130patient 028, cancer, homogenized [OPG study]7.6721679
GSM549101patient 111, normal, homogenized [OPG study]7.7199179
GSM549105patient 128, normal, homogenized [OPG study]7.2507774
GSM549106patient 134, normal, homogenized [OPG study]6.126960
GSM549112patient 048, normal, homogenized [OPG study]7.3464875
GSM549125patient 011, cancer, homogenized [OPG study]7.0318472
GSM549127patient 024, cancer, homogenized [OPG study]7.3999875
GSM549135patient 035, cancer, homogenized [OPG study]8.5165585